2018
DOI: 10.1055/s-0037-1610395
|View full text |Cite
|
Sign up to set email alerts
|

Asymmetric Total Synthesis and Biological Evaluation of (+)-Cycloclavine

Abstract: The first total synthesis of natural (+)-cycloclavine uses a catalytic­ asymmetric cyclopropanation of allene, a regiospecific Pd-catalyzed­ enone formation, and two intramolecular Diels–Alder reactions for indole/indoline annulations. The binding properties of natural (+)- and unnatural (–)-cycloclavine on 16 CNS receptors revealed significant stereospecificity and unique binding profiles in comparison to LSD, psilocin, and DMT. Differential 5-HT affinities, as well as novel sigma­-1 receptor properties bode … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 25 publications
0
13
0
Order By: Relevance
“… Dirhodium(II,II) complexes containing O , O '‐bridging ligands with structural motive OOCCHHetR; Het=nitrogen, R=tertiary substituent: V1 , [230] V2 , [231] V3 , [231] V4 , [239] V5 , [239] V6 , [240] V7 , [241] V8 , [236] V9 , [242] V10 , [243] V11 , [239] V12 , [244] V13 , [245] V14 , [246] V15 , [239] V16 , [227] V17 , [231] V18 , [235] V19 , [247] V20 , [247] V21 , [247] V22 , [229] V23 , [229] V24 , [248] V25 , [249] V26 [248] …”
Section: Overview Of Rh2a4 Paddlewheel Complexesmentioning
confidence: 99%
“… Dirhodium(II,II) complexes containing O , O '‐bridging ligands with structural motive OOCCHHetR; Het=nitrogen, R=tertiary substituent: V1 , [230] V2 , [231] V3 , [231] V4 , [239] V5 , [239] V6 , [240] V7 , [241] V8 , [236] V9 , [242] V10 , [243] V11 , [239] V12 , [244] V13 , [245] V14 , [246] V15 , [239] V16 , [227] V17 , [231] V18 , [235] V19 , [247] V20 , [247] V21 , [247] V22 , [229] V23 , [229] V24 , [248] V25 , [249] V26 [248] …”
Section: Overview Of Rh2a4 Paddlewheel Complexesmentioning
confidence: 99%
“…Methylenecyclopropanes (MCPs) are readily accessible four-carbon synthons for the synthesis of natural products as well as medical intermediates. As the smallest carbocycle with an exomethylene moiety, MCPs have a unique character and display diverse and valuable reactivity under transition-metal catalysis . In recent years, Shi’s group together with other research groups have worked toward significantly broadening the reaction patterns of MCPs under homogeneous gold catalysis.…”
Section: Gold-catalyzed Conversion Of Methylenecyclopropanes (Mcps)mentioning
confidence: 99%
“…2−4 In comparison to investigations of lysergic acid amides, the therapeutic potential of many other ergot alkaloids has remained underutilized, in spite of their frequently more selective dopamine and serotonin receptor binding profiles. 5,6 For example, (+)-and (−)-cycloclavine were found to show increased selectivity for dopamine D 3 and serotonin 5-HT 1A and 5-HT 2A central nervous system (CNS) receptors, 7,8 and indole fluorination of (+)-lysergol enhanced selectivity among 5-HT receptors compared to D-LSD. 9 Selective agonism at 5-HT 1−7 receptors is a target profile for the treatment of neuropsychiatric conditions, with the potential to yield new classes of therapeutics.…”
mentioning
confidence: 99%
“…Recent clinical results have renewed the interest in d -lysergic acid diethylamide ( d -LSD), first marketed as Delysid by Sandoz Ltd. in 1947, as a medication for depression, anxiety, neurodegeneration, and substance abuse disorders . However, given the strong hallucinogenicity and adverse side effects associated with d -LSD, establishing effective dosing regimens in a controlled clinical environment has remained a challenge. In comparison to investigations of lysergic acid amides, the therapeutic potential of many other ergot alkaloids has remained underutilized, in spite of their frequently more selective dopamine and serotonin receptor binding profiles. , For example, (+)- and (−)-cycloclavine were found to show increased selectivity for dopamine D 3 and serotonin 5-HT 1A and 5-HT 2A central nervous system (CNS) receptors, , and indole fluorination of (+)-lysergol enhanced selectivity among 5-HT receptors compared to d -LSD . Selective agonism at 5-HT 1–7 receptors is a target profile for the treatment of neuropsychiatric conditions, with the potential to yield new classes of therapeutics. , Furthermore, structural modifications of ergot alkaloids may deliver more effective therapeutic agents compared to the available portfolio of natural products and lysergate amides and avoid ergotism, a disease causing convulsions and gangrene.…”
mentioning
confidence: 99%